Roche Holding AG (LTS:0QOK)
CHF 263.05 -1.65 (-0.62%) Market Cap: 211.30 Bil Enterprise Value: 236.93 Bil PE Ratio: 19.78 PB Ratio: 7.21 GF Score: 86/100

Q1 2019 Roche Holding AG Corporate Sales Call Transcript

Apr 17, 2019 / 12:00PM GMT
Release Date Price: CHF266.5 (-1.28%)
Operator

Ladies and gentlemen, welcome to the Roche's First Quarter Sales 2019 Audio Webcast and Conference Call. I'm Sherry, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Dr. Severin Schwan, CEO of the Roche Group. Please go ahead, sir.

Severin Schwan
Roche Holding AG - CEO & Executive Director

Thank you, and welcome to our briefing on the quarter 1 sales. Going right into the presentation on Slide 6, you've seen that we started with strong sales growth into the current year, 10 percentage points up in Pharma, very much driven by the newly launched medicines; 1% in Diagnostics, so 8% sales growth for the group. You see on Slide 7, we keep a good momentum on a quarterly basis. And turning to Slide 8, we have now 27% of our Pharma sales coming from the more recently launched medicines. I mean, just to highlight 3 of them: OCREVUS, as you know, the best launch ever at Roche, continues to grow

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot